complete
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patients were confirmed to have solid pancreatic masses by at least a single investigational modality, mainly computed tomography (CT), magnetic resonance imaging (MRI) or EUS.
Exclusion criteria
Exclusion criteria: 1) bleeding tendencies (international normalized ratio <1.5 [0.85&#8211;1.25] or platelet count <80,000/mm3 [150,000&#8211;450,000/mm3]) 2) the inability to sample the lesion because of the presence of intervening blood vessels or altered gastrointestinal anatomy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| diagnostic accuracy | — |
Secondary
| Measure | Time frame |
|---|---|
| the rate of technical failure, complication and number of needle passes for diagnosis | — |
Countries
Asia(except Japan)
Contacts
SoonChunHyang University School of Medicine Digestive Disease Center and Research Institute, Department of Internal Medicine